Clinical Trial Update: Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal cisplatin for recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Liposomal Cisplatin (liposomal cisplatin)

Snippet

Sponsor: NYU Langone Health | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED